Regal Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Sell
4,280
-150
-3% -$51.3K 0.08% 247
2026
Q1
$1.56M Sell
4,430
-579
-12% -$206K 0.09% 226
2025
Q4
$1.64M Buy
5,009
+230
+5% +$73K 0.1% 218
2025
Q3
$1.35M Buy
4,779
+179
+4% +$51.9K 0.09% 219
2025
Q2
$1.28M Buy
4,600
+464
+11% +$131K 0.1% 203
2025
Q1
$1.29M Sell
4,136
-18
-0.4% -$5.32K 0.1% 189
2024
Q4
$1.08M Buy
4,154
+415
+11% +$123K 0.08% 215
2024
Q3
$1.2M Sell
3,739
-432
-10% -$141K 0.08% 227
2024
Q2
$1.3M Buy
4,171
+63
+2% +$18.5K 0.09% 220
2024
Q1
$1.17M Buy
4,108
+763
+23% +$223K 0.08% 231
2023
Q4
$963K Sell
3,345
-61
-2% -$16.6K 0.07% 231
2023
Q3
$915K Buy
3,406
+112
+3% +$27.9K 0.08% 221
2023
Q2
$731K Buy
3,294
+90
+3% +$20.9K 0.06% 236
2023
Q1
$775K Buy
3,204
+90
+3% +$22.1K 0.07% 223
2022
Q4
$818K Buy
3,114
+27
+0.9% +$7.24K 0.08% 209
2022
Q3
$696K Sell
3,087
-212
-6% -$51.4K 0.07% 219
2022
Q2
$803K Sell
3,299
-484
-13% -$119K 0.08% 216
2022
Q1
$915K Buy
3,783
+140
+4% +$32.2K 0.08% 225
2021
Q4
$820K Buy
3,643
+77
+2% +$16.3K 0.07% 269
2021
Q3
$758K Buy
3,566
+385
+12% +$88.6K 0.07% 278
2021
Q2
$775K Buy
+3,181
New +$783K 0.08% 259
2021
Q1
Sell
-4,366
Closed -$1M 44
2020
Q4
$1M Buy
+4,366
New +$1.01M 0.11% 177
2020
Q1
Sell
-2,359
Closed -$569K 42
2019
Q4
$569K Sell
2,359
-133
-5% -$29.3K 0.1% 185
2019
Q3
$482K Sell
2,492
-68
-3% -$13.1K 0.09% 193
2019
Q2
$472K Buy
2,560
+535
+26% +$95.8K 0.09% 197
2019
Q1
$385K Sell
2,025
-130
-6% -$24.8K 0.08% 213
2018
Q4
$419K Sell
2,155
-377
-15% -$73.5K 0.09% 199
2018
Q3
$525K Buy
2,532
+804
+47% +$158K 0.11% 186
2018
Q2
$319K Sell
1,728
-216
-11% -$38.2K 0.1% 203
2018
Q1
$331K Sell
1,944
-11,299
-85% -$2.07M 0.07% 216
2017
Q4
$2.3M Sell
13,243
-175
-1% -$31K 0.51% 60
2017
Q3
$2.5M Sell
13,418
-727
-5% -$129K 0.58% 49
2017
Q2
$2.44M Sell
14,145
-1,591
-10% -$259K 0.6% 53
2017
Q1
$2.58M Sell
15,736
-2,072
-12% -$344K 0.67% 49
2016
Q4
$2.6M Sell
17,808
-1,802
-9% -$271K 0.72% 53
2016
Q3
$3.27M Sell
19,610
-1,256
-6% -$212K 0.93% 27
2016
Q2
$3.17M Sell
20,866
-327
-2% -$50.8K 0.87% 31
2016
Q1
$3.18M Buy
21,193
+19,914
+1,557% +$2.96M 0.86% 37
2015
Q4
$207K Buy
1,279
+354
+38% +$55.6K 0.05% 241
2015
Q3
$127K Buy
925
+644
+229% +$102K 0.03% 313
2015
Q2
$43K Buy
281
+81
+41% +$13K 0.01% 442
2015
Q1
$32K Sell
200
-100
-33% -$15.7K 0.01% 496
2014
Q4
$48K Hold
300
0.01% 400
2014
Q3
$42K Hold
300
0.01% 434
2014
Q2
$36K Sell
300
-8
-3% -$926 0.01% 438
2014
Q1
$38K Buy
308
+8
+3% +$970 0.02% 389
2013
Q4
$34K Hold
300
0.02% 350
2013
Q3
$34K Hold
300
0.02% 366
2013
Q2
$30K Buy
+300
New +$31.1K 0.02% 374

Other funds holding AMGN

Regal Investment Advisors's AMGN Position: Q2 2026 in Review

Regal Investment Advisors reduced its Amgen (AMGN) stake by 3.4% in Q2 2026, selling an estimated $51.3K and leaving 4,280 shares worth $1.55M. The position accounts for 0.08% of the portfolio, ranked #247.

Regal Investment Advisors first reported a position in AMGN in Q2 2013 and has held it in 49 quarters since. The position peaked at $3.27M in Q3 2016. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Regal Investment Advisors held 4,280 shares of Amgen worth $1.55M as of Q2 2026.
  • Regal Investment Advisors sold 150 Amgen shares in Q2 2026, an estimated $51.3K.
  • Amgen made up 0.08% of Regal Investment Advisors's portfolio in Q2 2026, its #247 holding.
  • Regal Investment Advisors first reported a position in Amgen in Q2 2013 and has held it in 49 quarters since.
  • Regal Investment Advisors's Amgen position peaked at $3.27M in Q3 2016.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Regal Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.